Elanco Animal Health Inc. ELAN Business Segments — Marketing and selling
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Elanco Animal Health Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Elanco Animal Health Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Elanco Animal Health Inc.'s business segments — marketing and selling.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Elanco Animal Health Inc.'s business segments — marketing and selling?
- Elanco Animal Health Inc. (ELAN) reported business segments — marketing and selling of $256M in Q1 2026.
- How has Elanco Animal Health Inc.'s business segments — marketing and selling changed year-over-year?
- Elanco Animal Health Inc.'s business segments — marketing and selling increased by 13.8% year-over-year, from $225M to $256M.
- What is the long-term trend for Elanco Animal Health Inc.'s business segments — marketing and selling?
- Over 3 years (2022 to 2025), Elanco Animal Health Inc.'s business segments — marketing and selling has grown at a 6.2% compound annual growth rate (CAGR), from $770M to $923M.
- What does business segments — marketing and selling mean?
- Expenses related to marketing and selling products to customers.
- How do you interpret business segments — marketing and selling?
- An increase may signal aggressive growth strategies, while a decrease could indicate cost-cutting or reduced market support.
- How does business segments — marketing and selling compare across companies?
- Standard Selling, General, and Administrative (SG&A) component across the industry.